Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integral Strategy for Joint Management of DM2 and Pulmonary TB
NCT03277742Withdrawn
- Sponsor
- Instituto Nacional de Salud Pública
- Start
- Sep 2017
- Primary completion
- May 2020
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Instituto Nacional de Salud Pública. Primary endpoints: Treatment success at 6 months and Blood glucose control at 6 months. Planned start Sep 2017; status: withdrawn.
Beyond the preview
Go deeper on NCT03277742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03277742.